UNIGE document Scientific Article
previous document  unige:140370  next document
add to browser collection
Title

Biomarker Matrix to Track Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease

Authors
Ferrari, Clarissa
Macis, Ambra
Jovicich, Jorge
Albani, Diego
Babiloni, Claudio
Cavaliere, Libera
Didic, Mira
show hidden authors show all authors [1 - 30]
Collaboration
Published in Journal of Alzheimer's Disease. 2019, vol. 69, no. 1, p. 49-58
Abstract Assessment of human brain atrophy in temporal regions using magnetic resonance imaging (MRI), resting state functional MRI connectivity in the left parietal cortex, and limbic electroencephalographic (rsEEG) rhythms as well as plasma amyloid peptide 42 (Aβ42) has shown that each is a promising biomarker of disease progression in amnestic mild cognitive impairment (aMCI) patients with prodromal Alzheimer's disease (AD). However, the value of their combined use is unknown.
Keywords Alzheimer’s diseaseBiomarker matricesClinical trialMagnetic resonance imagingMild cognitive impairment
Identifiers
PMID: 30958351
Full text
Article (Published version) (148 Kb) - public document Free access
Structures
Research group Troubles de mémoire et maladie d'Alzeimer (935)
Citation
(ISO format)
MARIZZONI, Moira et al. Biomarker Matrix to Track Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease. In: Journal of Alzheimer's Disease, 2019, vol. 69, n° 1, p. 49-58. doi: 10.3233/JAD-181016 https://archive-ouverte.unige.ch/unige:140370

148 hits

153 downloads

Update

Deposited on : 2020-08-26

Export document
Format :
Citation style :